Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Altona Diagnostics Receives Emergency Use Authorization from US FDA for RealStar SARS-CoV-2 RT-PCR Kit US

By HospiMedica International staff writers
Posted on 01 May 2020
Altona Diagnostics GmbH (Hamburg, Germany) has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its RealStar SARS-CoV-2 RT-PCR Kit US. More...


The real-time Reverse Transcription/Polymerase Chain Reaction (RT-PCR) based molecular diagnostic test can be used under the EUA by authorized US laboratories for the in vitro qualitative detection of SARS-CoV-2 RNA in upper respiratory samples from individuals, who are suspected of COVID-19

The RealStar SARS-CoV-2 RT-PCR Kit US is authorized to be used within a workflow consisting of nucleic acid extraction using the AltoStar Automation System AM16 in combination with the AltoStar Purification Kit 1.5 and the AltoStar Internal Control 1.5 from altona,s followed by amplification and detection of SARS-CoV-2 specific RNA with the CFX96 real-time PCR instruments from Bio-Rad.


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Rapid Sepsis Test
SeptiCyte RAPID
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
image: Principles of SMEAR-ULM. (Lai, Y., Argüello, A.N., Liu, M. et al., Nature Sensors (2026). DOI: 10.1038/s44460-026-00078-4)

“Intelligent Tattoo” Method Detects Early Melanoma Signals

Melanoma is a lethal skin cancer in which earlier detection drives better outcomes. Current evaluation relies on visual inspection followed by biopsy, which can miss nascent lesions and lead to unnecessary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.